Literature DB >> 22500542

Ethical framework for medication discontinuation in nursing home residents with limited life expectancy.

Jennifer Tjia1, Jane Givens.   

Abstract

A recent editorial by health economist Victor Fuchs summarized the current challenges with health care delivery in this way: “Most physicians want to deliver ‘appropriate’ care. Most want to practice ‘ethically’, but it is difficult to know what is ‘appropriate’ and what is ‘ethical’. This characterization is particularly true for medication use and deprescribing in elderly NH residents with limited life expectancy. Medical ethics sets 4 key principles (beneficence, nonmaleficence, patient autonomy, and justice) to guide practice. However, decisional conflicts will continue between providers and patients, and physicians will continue to struggle with the dilemma of balancing the primacy of patient welfare, values, and beliefs against the desire for promising, but often minimally beneficial and harmful, medications that threaten limited clinical resources. Despite these challenges, physicians should be able to perform systematic medication reviews and monitor discontinuation trials in their NH patients for whom this is consistent with their goals of care.

Entities:  

Mesh:

Year:  2012        PMID: 22500542     DOI: 10.1016/j.cger.2012.01.010

Source DB:  PubMed          Journal:  Clin Geriatr Med        ISSN: 0749-0690            Impact factor:   3.076


  5 in total

Review 1.  Deprescribing in Older Adults With Cardiovascular Disease.

Authors:  Ashok Krishnaswami; Michael A Steinman; Parag Goyal; Andrew R Zullo; Timothy S Anderson; Kim K Birtcher; Sarah J Goodlin; Mathew S Maurer; Karen P Alexander; Michael W Rich; Jennifer Tjia
Journal:  J Am Coll Cardiol       Date:  2019-05-28       Impact factor: 24.094

2.  The Ethics of Deprescribing in Older Adults.

Authors:  Emily Reeve; Petra Denig; Sarah N Hilmer; Ruud Ter Meulen
Journal:  J Bioeth Inq       Date:  2016-07-14       Impact factor: 1.352

3.  Perceptions of Statin Discontinuation among Patients with Life-Limiting Illness.

Authors:  Jennifer Tjia; Jean S Kutner; Christine S Ritchie; Patrick J Blatchford; Rachael E Bennett Kendrick; Maryjo Prince-Paul; Tamara J Somers; Mary Lynn McPherson; Jeff A Sloan; Amy P Abernethy; Jon P Furuno
Journal:  J Palliat Med       Date:  2017-05-18       Impact factor: 2.947

Review 4.  Studies to reduce unnecessary medication use in frail older adults: a systematic review.

Authors:  Jennifer Tjia; Sarah J Velten; Carole Parsons; Sruthi Valluri; Becky A Briesacher
Journal:  Drugs Aging       Date:  2013-05       Impact factor: 3.923

Review 5.  Adverse drug reactions in older adults: a narrative review of the literature.

Authors:  Maria Beatrice Zazzara; Katie Palmer; Davide Liborio Vetrano; Angelo Carfì; Graziano Onder
Journal:  Eur Geriatr Med       Date:  2021-03-18       Impact factor: 1.710

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.